When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Emtricitabine/tenofovir - Wikipedia

   en.wikipedia.org/wiki/Emtricitabine/tenofovir

   Effectiveness of PrEP for prevention of infection is reliant on an individual's ability to take the medication consistently. [20] Emtricitabine/tenofovir is also used for HIV post-exposure prophylaxis. People who start taking emtricitabine/tenofovir see HIV reduction benefits up to 72 hours after starting, but the medicine must be taken for ...

3. Pre-exposure prophylaxis for HIV prevention - Wikipedia

   en.wikipedia.org/wiki/Pre-exposure_prophylaxis...

   There has been some evidence that other regimens, like ones based on the antiretroviral agent Maraviroc, could potentially prevent HIV infection. [102] Similarly, researchers are investigating whether drugs could be used in ways other than a daily pill to prevent HIV, including PrEP-releasing implants or rectally administered PrEP. [103]

4. Zidovudine - Wikipedia

   en.wikipedia.org/wiki/Zidovudine

   AZT was usually dosed twice a day in combination with other antiretroviral therapies. This approach is referred to as Highly Active Antiretroviral Therapy and is used to prevent the likelihood of HIV resistance. [11] [12] As of 2019, the standard is a three-drug once-daily oral treatment that can include AZT. [13]

5. Long-acting drugs to prevent HIV may be key to beating the ...

   www.aol.com/news/long-acting-drugs-prevent-hiv...

   New forms of pre-exposure prophylaxis, or PrEP, could be used by groups who find daily preventive medications too burdensome.

6. Management of HIV/AIDS - Wikipedia

   en.wikipedia.org/wiki/Management_of_HIV/AIDS

   Because of the complexity of selecting and following a regimen, the potential for side effects, and the importance of taking medications regularly to prevent viral resistance, such organizations emphasize the importance of involving patients in therapy choices and recommend analyzing the risks and the potential benefits. [7]

7. Tenofovir disoproxil - Wikipedia

   en.wikipedia.org/wiki/Tenofovir_disoproxil

   Tenofovir disoproxil is generally well tolerated with low discontinuation rates among the HIV and chronic hepatitis B population. [13] There are no contraindications for use of this drug. [10] The most commonly reported side effects due to use of tenofovir disoproxil were dizziness, nausea, and diarrhea. [13]